monoaminergic


Also found in: Dictionary, Wikipedia.

monoaminergic

 [mon″o-am″in-er´jik]
of or pertaining to neurons that secrete the monoamine neurotransmitters dopamine, norepinephrine, and serotonin.

mon·o·am·i·ner·gic

(mon'ō-am'i-nĕr'jik),
Referring to nerve cells or fibers that transmit nervous impulses by the medium of a catecholamine or indolamine.
[monoamine + G. ergon, work]

monoaminergic

/mono·am·in·er·gic/ (-am″in-er´jik) of or pertaining to neurons that secrete monoamine neurotransmitters (e.g., dopamine, serotonin).

mon·o·am·i·ner·gic

(mon'ō-am'i-nĕr'jik)
Referring to nerve cells or fibers that transmit nervous impulses by the medium of a catecholamine or indolamine.
[monoamine + G. ergon, work]

monoaminergic

of or pertaining to neurons that secrete the monoamine neurotransmitters dopamine, norepinephrine and serotonin.
References in periodicals archive ?
There is a hypothesis that claims that the monoaminergic deficits and lesions of frontal-subcortical circuits are the same in the brain of patients with PD and those with depression [118].
Medical treatment: The investigators who think that the dopaminergic cell groups in the monoaminergic pathways are important recommend use of bromocriptine to reverse the symptoms of akinetic mutism (11, 29).
Monoaminergic projection systems may be more suited for exerting modulatory functions.
9) The vesicular monoamine transporter (VMAT) exists in 2 isoforms (VMAT1 and VMAT2) that vary in distribution, with VMAT1 expressed mainly in the peripheral nervous system and VMAT2 expressed mainly in monoaminergic cells of the central nervous system.
Role of nitric oxide in the regulation of monoaminergic neurotransmission.
These cells also express the vesicular monoamine transporter type 2 (VMAT2), suggesting a role of monoaminergic transmission in the regulation of ghrelin secretion (2).
The efficacy of antidepressants and other serotonin-modulating drugs in the treatment of migraine has suggested that monoaminergic pathways are involved in the etiology of migraine," Dr.
It has also been demonstrated that methamphetamine damages monoaminergic terminals and transporters in the striatum, both in humans and laboratory animals (Volkow, Chang, Wang, Fowler, Leonido-Yee, Franceschi, et al.
The action of these cytokines on the Central Nervous System (CNS) generates changes in behavior, the central monoaminergic metabolism and the activation of the hypothalamic-pituitary-adrenal axis (HPA) (Dantzer et al.